Development and in vitro characterization of mebendazole delayed release tablet for colonic drug delivery

被引:0
作者
Baviskar, Dheeraj [1 ]
Rajput, Amarjit [1 ]
Bare, Kapil [1 ]
Biranwar, Yogeshkumar [1 ]
Chaudhari, Hiralal [1 ]
Narkhede, Deepak [1 ]
Jain, Dinesh [2 ]
机构
[1] Inst Pharmaceut Educ, Tal Shirpur, MS, India
[2] IPS Acad, Coll Pharm, Indore, MP, India
关键词
Mebendazole; Eudragit; PVP K30; colon targeted tablet;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The main objective behind this study was to formulate delayed release colon targeted tablet of Mebendazole by using different polymers. The precompressional parameters of powder blend were studied. The wet granulation method was used for the preparation of tablets. The tablets of all formulation were subjected for different physicochemical evaluation. The drug-excipient interaction study was carried out by using Fourier transforms Infrared spectroscopy (FTIR). The in vitro evaluation was carried out at different pH ranges (0.1M HCl, 6.8 and 7.4 Phosphate buffer) for the prepared tablets. From the stability, Fourier transform infra-red spectroscopy studies Mebendazole tablet does not show any interaction between drug and polymer. The prepared tablets were complied all the physicochemical test as per official limit. The formulated (M3) batch shows better sustained release 99.89% over a period of 12 hours and the data was fitted into Korsemeyer-Peppas kinetic equation. The result indicates that Mebendazole colon targeted matrix tablet remain stable in the stomach and shows better release into the colon with the help of pH dependent synthetic polymers.
引用
收藏
页码:249 / 253
页数:5
相关论文
共 14 条
  • [1] Abdul B., 2003, Pharmtech, P185
  • [2] Chemically treated hard gelatin capsules for colon-targeted drug delivery: A novel approach
    Bajpai, SK
    Bajpai, M
    Dengre, R
    [J]. JOURNAL OF APPLIED POLYMER SCIENCE, 2003, 89 (08) : 2277 - 2282
  • [3] Chein Y.W., 1992, Oral drug delivery and delivery systems, P139, DOI DOI 10.1002/BDD.2510040414
  • [4] Chourasia MK, 2003, J PHARM PHARM SCI, V6, P33
  • [5] Glibert SB, 2002, MODERN PHARM, P527
  • [6] Indian Pharmacopoeia, 2010, INDIAN PHARMACOPOEIA, V2, P1636
  • [7] Development of colon targeted drug delivery systems for mebendazole
    Krishnaiah, YSR
    Raju, PV
    Kumar, BD
    Bhaskar, P
    Satyanarayana, V
    [J]. JOURNAL OF CONTROLLED RELEASE, 2001, 77 (1-2) : 87 - 95
  • [8] mathiowitz Edith, 2003, ENCY CONTROLLED DRUG, P698
  • [9] Optimized prodrug approach: A means for achieving enhanced anti-inflammatory potential in experimentally induced colitis
    Philip, Anil K.
    Dabas, Sunny
    Pathak, Kamla
    [J]. JOURNAL OF DRUG TARGETING, 2009, 17 (03) : 235 - 241
  • [10] Rang HP, 2003, PHARMACOLOGY, P157